The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 09, 2022
Filed:
Sep. 18, 2019
Applicants:
H. Lee Moffitt Cancer Center and Research Institute, Inc., Tampa, FL (US);
University of South Florida, Tampa, FL (US);
Wake Forest University, Winston-Salem, NC (US);
Modulation Therapeutics, Inc., Morgantown, WV (US);
Inventors:
David Morse, Tampa, FL (US);
Robert Gillies, Tampa, FL (US);
Mark Mclaughlin, Tampa, FL (US);
Thaddeus Wadas, Winston-Salem, NC (US);
Hyun Joo Kil, Lutz, FL (US);
Narges Tafreshi, Tampa, FL (US);
Assignee:
Other;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 51/08 (2006.01); A61P 35/04 (2006.01); A61K 38/00 (2006.01); C07K 7/06 (2006.01); G01N 33/574 (2006.01); C07K 14/705 (2006.01); A61K 38/08 (2019.01);
U.S. Cl.
CPC ...
A61K 51/088 (2013.01); A61K 38/08 (2013.01); A61P 35/04 (2018.01); C07K 7/06 (2013.01); C07K 14/705 (2013.01); G01N 33/5743 (2013.01); A61K 38/00 (2013.01);
Abstract
The subject matter disclosed herein relates generally to cancer therapy and to anti-cancer compounds and imaging agents. More specifically, the subject matter disclosed herein relates to agents that target MC1R and their use in the treatment of cancer. Methods of screening for MC1R targeted agents are also disclosed.